2/253/2143242848

您所在的位置:网站首页 2/253/2143242848  
FTBMT a Novel and Selective GPR52 Agonist Demonstrates

data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/28851764FTBMT, a Novel and Selective GPR52 Agonist, Demonstrates ... - PubMed网页In the current study, we investigated the in vitro and in vivo pharmacologic activities of a novel GPR52 agonist, 4-(3-(3-fluoro-5-(trifluoromethyl)benzyl)-5-methyl-1H-1,2,4-triazol-1-yl)-2-methylbenzamide (FTBMT). FTBMT functioned as a selective GPR52 agonist in vitro and in vivo, as demonstrated by the activation of Camp signaling in striatal ...

发布时间:2024-07-10
Organizing Babylon

data-id="" iid="">Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/10.1111/1467-9299.00100Organizing Babylon - On the Different Conceptions of Policy Networks网页2002年12月17日 · Volume 76, Issue 2 p. 253-273. Organizing Babylon - On the Different Conceptions of Policy Networks. Tanja A. Börzel, Tanja A. Börzel. Department of Social and Political Sciences, The European University Institute, Florence, Italy. Search for more papers by this author. Tanja A. Börzel,

发布时间:2024-07-10
From speechlessness to narrative the cases of Holocaust

data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/16454374From speechlessness to narrative: the cases of Holocaust网页From speechlessness to narrative: the cases of Holocaust historians and of psychiatrically hospitalized survivors

发布时间:2024-07-10
All

data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/27017420All-Cause Mortality Attributable to Sitting Time: Analysis of …网页Gains in life expectancy related to the elimination of sitting time >3 hours/day was estimated using life table analysis. Results: Sitting time was responsible for 3.8% of all-cause mortality (about 433,000 deaths/year) among those 54 countries. All-cause mortality due to sitting time was higher in the countries from the Western Pacific region ...

发布时间:2024-07-10
Genomic Characteristics of Triple

data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/31704731Genomic Characteristics of Triple-Negative Breast Cancer ... - PubMed网页The heterogeneity of triple-negative breast cancer (TNBC) poses difficulties for suitable treatment and leads to poor outcome. This study aimed to define a consensus molecular subtype (CMS) of TNBC and thus elucidate genomic characteristics and relevant therapy. We integrated the expression profiles …

发布时间:2024-07-10

今日新闻


    推荐新闻


    专题文章

      CopyRight 2018-2019 实验室设备网 版权所有